How Pfizer Makes Its Covid-19 Vaccine
How Pfizer Makes Its Covid-19 Vaccine
5/1/2021
link
summary
This interactive article by The New York Times provides detailed information about the Pfizer-BioNTech COVID-19 vaccine. It delves into the vaccine's development process, efficacy, side effects, and distribution plans. The article explains the mRNA technology used in the vaccine and how it stimulates an immune response. It also addresses common questions and concerns regarding the vaccine, such as its safety, effectiveness, and potential allergic reactions. The interactive nature of the article allows readers to explore different aspects of the vaccine and understand its significance in the fight against the global pandemic.
tags
covid-19 vaccine ꞏ pfizer ꞏ vaccination ꞏ coronavirus ꞏ health ꞏ public health ꞏ immunization ꞏ pandemic ꞏ covid-19 ꞏ coronavirus vaccine ꞏ mrna vaccine ꞏ covid-19 vaccination campaign ꞏ vaccine rollout ꞏ vaccine distribution ꞏ vaccine efficacy ꞏ vaccine safety ꞏ vaccine development ꞏ vaccine research ꞏ vaccine technology ꞏ infectious diseases ꞏ virus ꞏ immunology ꞏ epidemiology ꞏ healthcare ꞏ medical science ꞏ clinical trials ꞏ pfizer-biontech vaccine ꞏ vaccine effectiveness ꞏ vaccination progress ꞏ vaccine side effects ꞏ vaccination process ꞏ herd immunity ꞏ global health ꞏ public safety ꞏ pandemic response ꞏ healthcare workers ꞏ vaccine supply ꞏ vaccine production ꞏ vaccine logistics ꞏ vaccine hesitancy ꞏ vaccine administration ꞏ vaccine rollout plan ꞏ vaccine doses ꞏ vaccine priority groups ꞏ vaccination coverage ꞏ vaccine passports ꞏ vaccine tracking ꞏ vaccine misinformation ꞏ vaccine policies ꞏ vaccination rates